When and Where
Print your Invitation
Travelling / Transportation Info
Mark Your Calendar
Speakers / Posters Registration (Abstracts Submission)
Submit a Workshop
Become a Sponsor / Partner
Join MEMBS Committee
This page will be available by 1 August 2018
This page will be available by 1st October 2018
Dr. Yassine Amrani
Leicester Biomedical Research Center Respiratory Medicine, Department of Infection, Immunity and Inflammation
University of Leicester
Dr Yassine Amrani is an internationally-recognized medical researcher in the field of asthma pathogenesis with expertise in basic and experimental clinical medicine. He obtained his PhD in Respiratory Medicine with the highest honor “summa com laude” from the University of Strasbourg, France. He is a member of the Institute for Lung Health and Principal Investigator at Leicester Respiratory Biomedical Research Unit at Glenfield Hospital.
Main Research Interests:
Using translational “bench-to-bedside” approaches, Dr Amrani made key discoveries regarding the pathogenesis of severe asthma, a disease poorly controlled by current therapies. Throughout his career, Dr Amrani received over $6 million worth of research and programme grants (as PI, co-PI and collaborator) from National Institute of Health (US), American Lung Association (US), Parker B. Francis Foundation (US) and Welcome trust (UK). He received awards from various medical foundations: Parker B. Francis Fellowship Award (USA), Association Française pour la Recherche Thérapeutique, Fondation pour la Recherche Médicale (Paris, France), Association Claude Bernard and Foundation pour la Recherche Medicale (Paris, France). He has published over 100 peer-reviewed articles/reviews in top medical journals and wrote 10 book chapters in pulmonary medicine. His H-index is 38 (scopus). He has delivered over 50 lectures in different Universities and international meetings including American Thoracic Society and American Academy of Allergy Asthma and Immunology. He has served as a chair/member of committee panels for funding bodies (UK, Ireland, USA, France) and is an ad hoc reviewer for > 41 top journals (including Nature Com, Proc Natl Acad Sci USA, J Clin Invest, J Allergy Clin Immunol among others).